DescriptionCalcitriol (1,25?dihydroxyvitamin D?) is the active form of vitamin D, playing a crucial role in calcium and phosphate metabolism. It promotes intestinal calcium absorption, renal reabsorption, and bone mineralization, making it indispensable for research on hypocalcemia, secondary hyperparathyroidism, osteoporosis, and osteomalacia?.The Aogu formulation offers a precise 0.25??g dose in a soft capsule—ideal for controlled in vitro and in vivo studies. Manufactured by Hong Kong Aomei Pharmaceutical Co., it is registered with China’s NMPA (HC20230003), product code 86979136002533, and barcode 4895013212153.?? Strictly for laboratory research use only. Not approved for clinical, diagnostic, or veterinary use. Contents hide 1 Calcitriol Soft Capsules Product Specifications 2 Calcitriol Soft Capsules Mechanism & Research Applications 3 Calcitriol Soft Capsules Side Effects (Research Context) 4 Safety & Handling 5 Core Keywords 6 Research Use Disclaimer Calcitriol Soft Capsules Product SpecificationsParameterDetailsProduct NameCalcitriol Soft Capsules (Aogu)Generic NameCalcitriol (1,25?dihydroxyvitamin D?)CAS Number32222?06?3Molecular FormulaC??H??O?Molecular Weight–Dosage FormSoft gelatin capsuleStrength0.25??g per capsuleQuantity40 capsules per boxApproval NumberHC20230003 (China NMPA)Product Code86979136002533ManufacturerHong Kong Aomei Pharmaceutical Co. Ltd.Barcode4895013212153Storage ConditionsStore at 2–8?°C, protect from lightIntended UseLaboratory research onlyCalcitriol Soft Capsules Mechanism & Research ApplicationsCalcitriol acts as an agonist of the vitamin?D receptor (VDR), increasing calcium and phosphate absorption in the gut, decreasing renal excretion, and mobilizing calcium from bone — essential for research in:Bone metabolism and mineralization assaysHypocalcemia and hyperparathyroidism modelsOsteoporosis and osteomalacia studiesImmune modulation and cytokine regulation modelsRenal patient mineral handling assaysCalcitriol Soft Capsules Side Effects (Research Context)High-dose or prolonged calcitriol exposure may lead to:Hypercalcemia: symptoms include nausea, weakness, constipation, polyuriaHyperphosphatemia: may occur alongside calcium increasesDermal reactions with topical or contact exposureMonitor serum calcium and phosphate in in vivo studies.Safety & HandlingUse Restriction: Laboratory research only — not for human/clinical useHandling: Wear lab gloves; avoid ingestionStorage: Keep sealed at 2–8?°C, shielded from UV lightDisposal: Follow institutional chemical waste protocolsCore KeywordsCalcitriol soft capsules, Aogu calcitriol, 0.25??g vitamin D3 research, bone metabolism supplement, laboratory-grade calcitriol, NMPA HC20230003 calcitriol, Hong Kong Aomei calcitriol, wholesale calcitriol capsules, lab-use active vitamin DResearch Use DisclaimerThis product is exclusively for laboratory research use and is not approved for therapeutic, diagnostic, clinical, or veterinary applications. Misuse may cause safety or regulatory risks. Always follow institutional biosafety and chemical handling guidelines.
